Atrial Natriuretic Peptide for the Prevention of Contrast Induced Nephropathy: “What’s Old is New but at the Right Dose and Duration of Therapy!”

Por Chen, Horng H
Publicado em 2009

Is Cystatin C an Important Prognostic Marker Independent of Renal Function?

Por Chen, Horng H
Publicado em 2010

Beta Trace-Protein versus Cystatin C: Which is a Better Surrogate Marker of Renal Function versus Prognostic Indicator in Cardiovascular Diseases?

Por Chen, Horng H
Publicado em 2011

ROSE-AHF and Lessons Learned

Por Jain, Amit K., Chen, Horng H.
Publicado em 2014

The renal–cardiac connection in subjects with preserved ejection fraction: a population based study

Por Jain, Amit, Scott, Christopher, Chen, Horng H.
Publicado no ESC Heart Fail (2017)

Chronic natriuretic peptide protein therapeutics

Por Chen, Horng H, Cataliotti, Alessandro, Burnett, John C
Publicado em 2013

Changes in Diastolic Dysfunction in Diabetes Mellitus Over Time

Por From, Aaron M., Scott, Christopher G., Chen, Horng H.
Publicado em 2009

The Development of Heart Failure in Patients with Diabetes Mellitus and Preclinical Diastolic Dysfunction: A Population Based Study

Por From, Aaron M., Scott, Christopher G., Chen, Horng H.
Publicado em 2010

Preclinical Diastolic Dysfunction

Por Wan, Siu-Hin, Vogel, Mark W., Chen, Horng H
Publicado em 2013

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model

Por Ameenuddin, Syed, Oehler, Elise A, Burnett, John C, Chen, Horng H
Publicado em 2011

In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide

Por Lim, Soo Ghim, Venkatraman, Subbu S., Burnett, John C., Chen, Horng H.
Publicado em 2013

B-TYPE NATRIURETIC PEPTIDE: BEYOND A DIAGNOSTIC

Por Martin, Fernando L., Chen, Horng H., Cataliotti, Alessandro, Burnett, John C.
Publicado no Heart Fail Clin (2008)

The Natural History of Preclinical Diastolic Dysfunction: A Population Based Study

Por Vogel, Mark W., Slusser, Josh P., Hodge, David O., Chen, Horng H.
Publicado em 2012

THE NATURAL HISTORY OF PATIENTS WITH ISOLATED METABOLIC SYNDROME

Por Patel, Pratik A., Scott, Christopher G., Rodeheffer, Richard J., Chen, Horng H.
Publicado no Mayo Clin Proc (2016)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts

Por Ichiki, Tomoko, Huntley, Brenda K, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Publicado em 2009

B-Type Natriuretic Peptide and Extracellular Matrix Protein Interactions in Human Cardiac Fibroblasts

Por HUNTLEY, BRENDA K., ICHIKI, TOMOKO, SANGARALINGHAM, S. JESON, CHEN, HORNG H., BURNETT, JOHN C.
Publicado em 2010

Maximizing the Renal Cyclic 3′-5′-Guanosine Monophosphate System with Type V Phosphodiesterase Inhibition and Exogenous Natriuretic Peptide: A Novel Strategy to Improve Renal Funct...

Por Chen, Horng H., Huntley, Brenda K., Schirger, John A., Cataliotti, Alessandro, Burnett, John C.
Publicado em 2006

Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction

Por Chen, Horng H, Cataliotti, Alessandro, Martin, Fernando L, Schirger, John A, Burnett, John C
Publicado em 2009

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties

Por Chen, Horng H, Huntley, Brenda K, Cataliotti, Alessandro, Martin, Fernando L, Burnett, John C
Publicado em 2009

Nesiritide in Acute Decompensated Heart Failure: Current Status and Future Perspectives

Por Mohammed, Selma F., Korinek, Josef, Chen, Horng H., Burnett, John C., Redfield, Margaret M.
Publicado em 2008